Definition, pathogenesis, clinical manifestations, etiology and risk factors view in chinese. Allopurinol for the treatment of chronic kidney disease. Pdf allopurinol as a kidneyprotective, cardioprotective, and. Dose reductions are recommended in patients with renal. It is specifically used to prevent gout, prevent specific types of kidney stones. Even among individuals with normal renal function, the presence of hyperuricemia has been correlated with future incidence of renal impairment and increased healthcare utilization and costs 7, 8. Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigenb genotype and allopurinol dosing. Allopurinolinduced fever is often accompanied by hepatotoxicity, deterioration of renal function, severe rash, and eosinophilia 60 percent. Allopurinol as a kidneyprotective, cardioprotective, and antihypertensive agent. Dosing guidelines based on creatinine clearance have been proposed based on the recognition that dosages of. Allopurinol as a kidneyprotective, cardioprotective, and.
Oral doses in excess of 300 mgday should be given in divided doses, preferably after meals to minimize gastric irritation. Pdf allopurinoldose according to effect, not renal function. Selected from data included with permission and ed by first databank, inc. In patients with renal impairment, the allopurinol maximum dosage should be adjusted to creatinine clearance. How i treat acute myeloid leukemia presenting with. It is specifically used to prevent gout, prevent specific types of kidney stones and for the high uric acid levels that can occur with chemotherapy. A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. While there is wide interindividual variation in the oxypurinol concentration for a given allopurinol dose, there is a significant positive correlation between allopurinol dose and plasma oxypurinol concentration for a given individual. Daily doses recommended by the current renal dosing guidelines 1 fail to achieve the clinical target for plasma urate of. Little black book of geriatrics, 3rd edition karen, m. In 1984 a seminal paper on allopurinol toxicity in patients with renal insufficiency was published. Allopurinol, a widely used treatment for lowering serum urate levels, does not appear to increase risk of kidney deterioration in gout patients with normal or nearnormal kidney function. Allopurinol dosing in renal impairment walking the.
Epidemiology and risk factors for severe delayed drug. Normal serum urate levels are usually achieved in 1. Crude rates of renal disease were 192 per personyears with allopurinol and 338 per personyears with febuxostat. Allopurinol, sold under the brand name zyloprim among others, is a medication used to decrease high blood uric acid levels. Reproductive studies performed in rats and rabbits at doses up to twenty times usual human dose 5 mgkg per day concluded that there was no impaired fertility or harm to fetus due to allopurinol. Precautions and warnings with alprazolam there are many alprazolam precautions and warnings to be aware of before starting the medication.
Epidemiology and risk factors for severe delayed drug hypersensitivity reactions volume. However, in subjects with impaired renal function, febuxostat 40 mg was also superior to allopurinol 300 mg daily mild renal impair ment or 200 mg daily moderate renal impairment, sug gesting that treatment with either dose of febuxostat is more likely to achieve sua allopurinol is the mainstay of urate. In various analyses adjusted for baseline differences between allopurinol and febuxostat users, roughly 35% lower risk for. It is taken by mouth or injected into a vein common side effects when used by mouth include itchiness and rash. This approach generally helps to stabilize the patients gout despite a failure to achieve a.
Allopurinol should always be considered tumor lysis syndrome. Allopurinol does not increase chronic kidney disease risk. Dose adjustment of allopurinol in patients with kidney disease. Ask the experts allopurinol toxicity in renal insufficiency. Allopurinol is the mainstay of uratelowering therapy for patients with gout and impaired renal function. If the sua target cannot be achieved at this dose, the patient should be switched to febuxostat or given. For example, to help ensure safe treatment, you should let your healthcare provider know if you have liver or kidney disease, lung problems, or.
The risk of this allopurinol hypersensitivity syndrome ahs is increased in renal impairment. Renal impairment a high starting dose of allopurinol relative to renal function the hlab5801 genotype that is most prevalent in people of asian descent the clinical significance of reduced renal function in patients taking allopurinol is emphasised by international estimates that between 40% to 50% of patients with gout also have. Pdf allopurinol as a kidneyprotective, cardioprotective. Allopurinol, febuxostat, and risk for renal disease. Allopurinol dosing in patients with chronic kidney disease is the subject of ongoing controversy and active research. Although several dosing options can be considered, our own preference, based on published experience, is a dose of 1. Contraindications none except a hypersensitivity to allopurinol.
The prevalence of chronic kidney disease ckd has increased and will. Allopurinol is used to manage gout and works by reducing plasma urate concentrations. Cautions to reduce the risk of a gouty arthritis at the beginning of the therapy, nonsteroidal antiinflammatory drugs can be administered for approximately two months. Risk factors for toxicity to allopurinol allopurinol is a drug used to decrease the production of uric acid in the body. The aim of this study was to determine the effect of allopurinol on kidney function in hyperuricemic male veterans. Walking the tightrope between adequate urate lowering and adverse events article in seminars in dialysis 205. Extra caution should be exercised if renal function is poor see patients with renal impairment. Allopurinol drug monograph pediatric care online aap pointof. Clinical pharmacogenetics implementation consortium. Allopurinol dosing in renal impairment walking the tightrope he made himself out to be the man of the people why allopurinol is not used in acute gout attack it would therefore be sensible to take a decade or so to bring in this change. Renal dosing of allopurinol results in suboptimal gout. The impact of allopurinol, a uratelowering therapy, on renal function is unclear, especially in patients with chronic kidney disease who are at higher risk of hypersensitivity reaction. For these reasons, adherence to the standard allopurinol dosing guidelines in renal failure is wise. Allopurinol dosing in patients with renal impairment paganz.
575 1026 189 176 55 52 1520 1416 1169 752 314 452 1433 1407 1141 320 924 230 472 579 953 967 484 313 132 684 612 6 91 64 1355 62 138 877 659 971 511 670 1247 1378 1079 817 723